Roche announced the release of NAVIFY Tumor Board 2.0, the first collaboration product from their partnership with GE Healthcare. Incorporating medical image viewing and storage capabilities with other patient data, the product enables tumor boards—multi-disciplinary teams who determine treatment plans for cancer patients—to have a more comprehensive view of each patient in one place.
Bringing together patient medical records from various systems for review by tumor boards can be time-consuming and cumbersome. The integration of GE Healthcare’s medical image viewer into NAVIFY Tumor Board v2.0 enables radiologists to upload their patient records to the same dashboard where patient files from other disciplines in the cancer care team are stored. Having complete patient diagnostic information in one location helps specialists use the limited time they have during tumor boards to review all relevant files quickly and align on the best possible treatment plan for each cancer patient.
The partnership combines Roche expertise in advanced lab testing and the GE Healthcare leadership in medical imaging and monitoring to provide an ecosystem of workflow solutions and apps on an shared integrated diagnostics platform. The companies are aiming to design products to enable seamless integration and analysis of comprehensive lab and medical imaging data, patient records, medical best practice, real-time monitoring, and the latest research outcomes. Ideally, clinicians will then have confidence that they are making the best possible treatment decision for each patient.
